植込み型除細動器市場：世界の産業分析、規模、シェア、成長、動向、予測、2023年から2031年

植込み型除細動器市場- レポートの範囲

世界の植込み型除細動器市場に関するTMRの調査レポートは、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界市場の収益を提供します。また、2023年から2031年までの世界市場の複合年間成長率（CAGR %）も掲載しています。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、植込み型除細動器市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

このレポートは、世界の植込み型除細動器市場の競合情勢を掘り下げています。世界の植込み型除細動器市場で活動する主要プレーヤーが特定され、これらはさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の植込み型除細動器市場のプレーヤーの属性です。

目次

第1章 序文

第2章 仮定と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

• イントロダクション
• 概要
• 市場力学
• 世界市場の分析と予測、2017～2031年

第5章 重要な洞察

• 世界における疾病の有病率と罹患率、主要国について
• 地域別/世界全体の規制シナリオ
• 主要製品/ブランド分析
• COVID-19のパンデミックが業界に与える影響

第6章 世界市場の分析と予測：製品別

• イントロダクションと定義
• 主な発見と開発
• 市場価値予測：製品別、2017-2031
  • 経静脈植込み型心臓除細動器（T-ICD）
    • 心臓再同期療法（CRT）
    • デュアルチャンバーICD
    • シングルチャンバーICD
  • 皮下植込み型心臓除細動器（S-ICD）
• 市場魅力分析：製品別

第7章 世界市場の分析と予測：エンドユーザー別

• イントロダクションと定義
• 主な発見と開発
• 市場価値予測：エンドユーザー別、2017-2031
  • 病院とクリニック
  • 外来手術センター
  • その他
• 市場魅力分析：エンドユーザー別

第8章 世界市場の分析と予測：地域別

• 主な調査結果
• 市場価値予測：地域別
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ
• 市場魅力分析：地域別

第9章 北米市場の分析と予測

第10章 欧州市場の分析と予測

第11章 アジア太平洋市場の分析と予測

第12章 ラテンアメリカ市場の分析と予測

第13章 中東およびアフリカ市場の分析と予測

第14章 競合情勢

• 市場企業- 競合マトリックス（企業の階層および規模別）
• 市場シェア分析：企業別（2022年）
• 企業プロファイル
  • Boston Scientific Corporation
  • BIOTRONIK
  • Medtronic
  • LivaNova
  • Abbott
  • MicroPort

List of Tables

• Table 01: Global Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031
• Table 02: Global Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031
• Table 03: Global Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Region, 2017-2031
• Table 04: North America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031
• Table 05: North America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031
• Table 06: North America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Country, 2017-2031
• Table 07: Europe Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031
• Table 08: Europe Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031
• Table 09: Europe Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
• Table 10: Asia Pacific Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031
• Table 11: Asia Pacific Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031
• Table 12: Asia Pacific Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
• Table 13: Latin America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031
• Table 14: Latin America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031
• Table 15: Latin America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031
• Table 16: Middle East & Africa Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Product, 2017-2031
• Table 17: Middle East & Africa Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by End-user, 2017-2031
• Table 18: Middle East & Africa Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

• Figure 01: Global Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, 2017-2031
• Figure 02: Global Implantable Cardioverter Defibrillator Market Value Share Analysis, by Product, 2022 and 2031
• Figure 03: Global Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by Product, 2023-2031
• Figure 04: Global Implantable Cardioverter Defibrillator Market Value Share Analysis, by End-user, 2022 and 2031
• Figure 05: Global Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by End-user, 2023-2031
• Figure 06: Global Implantable Cardioverter Defibrillator Market Value Share Analysis, by Region, 2022 and 2031
• Figure 07: Global Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by Region, 2023-2031
• Figure 08: North America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, 2017-2031
• Figure 09: North America Implantable Cardioverter Defibrillator Market Value Share Analysis, by Product, 2022 and 2031
• Figure 10: North America Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by Product, 2023-2031
• Figure 11: North America Implantable Cardioverter Defibrillator Market Value Share Analysis, by End-user, 2022 and 2031
• Figure 12: North America Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by End-user, 2023-2031
• Figure 13: North America Implantable Cardioverter Defibrillator Market Value Share Analysis, by Country, 2022 and 2031
• Figure 14: North America Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by Country, 2023-2031
• Figure 15: Europe Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, 2017-2031
• Figure 16: Europe Implantable Cardioverter Defibrillator Market Value Share Analysis, by Product, 2022 and 2031
• Figure 17: Europe Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by Product, 2023-2031
• Figure 18: Europe Implantable Cardioverter Defibrillator Market Value Share Analysis, by End-user, 2022 and 2031
• Figure 19: Europe Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by End-user, 2023-2031
• Figure 20: Europe Implantable Cardioverter Defibrillator Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
• Figure 21: Europe Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
• Figure 22: Asia Pacific Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, 2017-2031
• Figure 23: Asia Pacific Implantable Cardioverter Defibrillator Market Value Share Analysis, by Product, 2022 and 2031
• Figure 24: Asia Pacific Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by Product, 2023-2031
• Figure 25: Asia Pacific Implantable Cardioverter Defibrillator Market Value Share Analysis, by End-user, 2022 and 2031
• Figure 26: Asia Pacific Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by End-user, 2023-2031
• Figure 27: Asia Pacific Implantable Cardioverter Defibrillator Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
• Figure 28: Asia Pacific Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
• Figure 29: Latin America Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, 2017-2031
• Figure 30: Latin America Implantable Cardioverter Defibrillator Market Value Share Analysis, by Product, 2022 and 2031
• Figure 31: Latin America Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by Product, 2023-2031
• Figure 32: Latin America Implantable Cardioverter Defibrillator Market Value Share Analysis, by End-user, 2022 and 2031
• Figure 33: Latin America Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by End-user, 2023-2031
• Figure 34: Latin America Implantable Cardioverter Defibrillator Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
• Figure 35: Latin America Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
• Figure 36: Middle East & Africa Implantable Cardioverter Defibrillator Market Value (US$ Bn) Forecast, 2017-2031
• Figure 37: Middle East & Africa Implantable Cardioverter Defibrillator Market Value Share Analysis, by Product, 2022 and 2031
• Figure 38: Middle East & Africa Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by Product, 2023-2031
• Figure 39: Middle East & Africa Implantable Cardioverter Defibrillator Market Value Share Analysis, by End-user, 2022 and 2031
• Figure 40: Middle East & Africa Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by End-user, 2023-2031
• Figure 41: Middle East & Africa Implantable Cardioverter Defibrillator Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
• Figure 42: Middle East & Africa Implantable Cardioverter Defibrillator Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
• Figure 43: Global Implantable Cardioverter Defibrillator Market Share Analysis, by Company, 2022

Implantable Cardioverter Defibrillator Market - Scope of Report

TMR's report on the global Implantable Cardioverter Defibrillator market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Implantable Cardioverter Defibrillator market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Implantable Cardioverter Defibrillator market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Implantable Cardioverter Defibrillator market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Implantable Cardioverter Defibrillator market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Implantable Cardioverter Defibrillator market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Implantable Cardioverter Defibrillator market.

The report delves into the competitive landscape of the global Implantable Cardioverter Defibrillator market. Key players operating in the global Implantable Cardioverter Defibrillator market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Implantable Cardioverter Defibrillator market profiled in this report.

Key Questions Answered in Global Implantable Cardioverter Defibrillator Market Report:

• What is the sales/revenue generated by Implantable Cardioverter Defibrillator across all regions during the forecast period?
• What are the opportunities in the global Implantable Cardioverter Defibrillator market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Implantable Cardioverter Defibrillator Market - Research Objectives and Research Approach

The comprehensive report on the global Implantable Cardioverter Defibrillator market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Implantable Cardioverter Defibrillator market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Implantable Cardioverter Defibrillator market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Implantable Cardioverter Defibrillator Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Implantable Cardioverter Defibrillator Market Analysis and Forecast, 2017-2031
  • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

• 5.1. Disease Prevalence & Incidence Rate globally with key countries
• 5.2. Regulatory Scenario by Region/globally
• 5.3. Key Product/Brand Analysis
• 5.4. COVID-19 Pandemics Impact on Industry

6. Global Implantable Cardioverter Defibrillator Market Analysis and Forecast, by Product

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast, by Product, 2017-2031
  • 6.3.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
    • 6.3.1.1. Cardiac Resynchronization Therapy (CRT)
    • 6.3.1.2. Dual Chamber ICDs
    • 6.3.1.3. Single Chamber ICDs
  • 6.3.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
• 6.4. Market Attractiveness Analysis, by Product

7. Global Implantable Cardioverter Defibrillator Market Analysis and Forecast, by End-user

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast, by End-user, 2017-2031
  • 7.3.1. Hospitals & Clinics
  • 7.3.2. Ambulatory Surgery Centers
  • 7.3.3. Others
• 7.4. Market Attractiveness Analysis, by End-user

8. Global Implantable Cardioverter Defibrillator Market Analysis and Forecast, by Region

• 8.1. Key Findings
• 8.2. Market Value Forecast, by Region
  • 8.2.1. North America
  • 8.2.2. Europe
  • 8.2.3. Asia Pacific
  • 8.2.4. Latin America
  • 8.2.5. Middle East & Africa
• 8.3. Market Attractiveness Analysis, by Region

9. North America Implantable Cardioverter Defibrillator Market Analysis and Forecast

• 9.1. Introduction
  • 9.1.1. Key Findings
• 9.2. Market Value Forecast, by Product, 2017-2031
  • 9.2.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
    • 9.2.1.1. Cardiac Resynchronization Therapy (CRT)
    • 9.2.1.2. Dual Chamber ICDs
    • 9.2.1.3. Single Chamber ICDs
  • 9.2.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
• 9.3. Market Value Forecast, by End-user, 2017-2031
  • 9.3.1. Hospitals & Clinics
  • 9.3.2. Ambulatory Surgery Centers
  • 9.3.3. Others
• 9.4. Market Value Forecast, by Country, 2017-2031
  • 9.4.1. U.S.
  • 9.4.2. Canada
• 9.5. Market Attractiveness Analysis
  • 9.5.1. By Product
  • 9.5.2. By End-user
  • 9.5.3. By Country

10. Europe Implantable Cardioverter Defibrillator Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast, by Product, 2017-2031
  • 10.2.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
    • 10.2.1.1. Cardiac Resynchronization Therapy (CRT)
    • 10.2.1.2. Dual Chamber ICDs
    • 10.2.1.3. Single Chamber ICDs
  • 10.2.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
• 10.3. Market Value Forecast, by End-user, 2017-2031
  • 10.3.1. Hospitals & Clinics
  • 10.3.2. Ambulatory Surgery Centers
  • 10.3.3. Others
• 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 10.4.1. Germany
  • 10.4.2. U.K.
  • 10.4.3. France
  • 10.4.4. Spain
  • 10.4.5. Italy
  • 10.4.6. Rest of Europe
• 10.5. Market Attractiveness Analysis
  • 10.5.1. By Product
  • 10.5.2. By End-user
  • 10.5.3. By Country/Sub-region

11. Asia Pacific Implantable Cardioverter Defibrillator Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Product, 2017-2031
  • 11.2.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
    • 11.2.1.1. Cardiac Resynchronization Therapy (CRT)
    • 11.2.1.2. Dual Chamber ICDs
    • 11.2.1.3. Single Chamber ICDs
  • 11.2.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
• 11.3. Market Value Forecast, by End-user, 2017-2031
  • 11.3.1. Hospitals & Clinics
  • 11.3.2. Ambulatory Surgery Centers
  • 11.3.3. Others
• 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 11.4.1. China
  • 11.4.2. Japan
  • 11.4.3. India
  • 11.4.4. Australia & New Zealand
  • 11.4.5. Rest of Asia Pacific
• 11.5. Market Attractiveness Analysis
  • 11.5.1. By Product
  • 11.5.2. By End-user
  • 11.5.3. By Country/Sub-region

12. Latin America Implantable Cardioverter Defibrillator Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Product, 2017-2031
  • 12.2.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
    • 12.2.1.1. Cardiac Resynchronization Therapy (CRT)
    • 12.2.1.2. Dual Chamber ICDs
    • 12.2.1.3. Single Chamber ICDs
  • 12.2.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
• 12.3. Market Value Forecast, by End-user, 2017-2031
  • 12.3.1. Hospitals & Clinics
  • 12.3.2. Ambulatory Surgery Centers
  • 12.3.3. Others
• 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 12.4.1. Brazil
  • 12.4.2. Mexico
  • 12.4.3. Rest of Latin America
• 12.5. Market Attractiveness Analysis
  • 12.5.1. By Product
  • 12.5.2. By End-user
  • 12.5.3. By Country/Sub-region

13. Middle East & Africa Implantable Cardioverter Defibrillator Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Product, 2017-2031
  • 13.2.1. Transvenous Implantable Cardiac Defibrillators (T-ICDs)
    • 13.2.1.1. Cardiac Resynchronization Therapy (CRT)
    • 13.2.1.2. Dual Chamber ICDs
    • 13.2.1.3. Single Chamber ICDs
  • 13.2.2. Subcutaneous Implantable Cardiac Defibrillators (S-ICD)
• 13.3. Market Value Forecast, by End-user, 2017-2031
  • 13.3.1. Hospitals & Clinics
  • 13.3.2. Ambulatory Surgery Centers
  • 13.3.3. Others
• 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
  • 13.4.1. GCC Countries
  • 13.4.2. South Africa
  • 13.4.3. Rest of Middle East & Africa
• 13.5. Market Attractiveness Analysis
  • 13.5.1. By Product
  • 13.5.2. By End-user
  • 13.5.3. By Country/Sub-region

14. Competition Landscape

• 14.1. Market Player - Competition Matrix (by tier and size of companies)
• 14.2. Market Share Analysis, by Company (2022)
• 14.3. Company Profiles
  • 14.3.1. Boston Scientific Corporation
    • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.1.2. Product Portfolio
    • 14.3.1.3. Financial Overview
    • 14.3.1.4. SWOT Analysis
    • 14.3.1.5. Strategic Overview
  • 14.3.2. BIOTRONIK
    • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.2.2. Product Portfolio
    • 14.3.2.3. Financial Overview
    • 14.3.2.4. SWOT Analysis
    • 14.3.2.5. Strategic Overview
  • 14.3.3. Medtronic
    • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.3.2. Product Portfolio
    • 14.3.3.3. Financial Overview
    • 14.3.3.4. SWOT Analysis
    • 14.3.3.5. Strategic Overview
  • 14.3.4. LivaNova
    • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.4.2. Product Portfolio
    • 14.3.4.3. Financial Overview
    • 14.3.4.4. SWOT Analysis
    • 14.3.4.5. Strategic Overview
  • 14.3.5. Abbott
    • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.5.2. Product Portfolio
    • 14.3.5.3. Financial Overview
    • 14.3.5.4. SWOT Analysis
    • 14.3.5.5. Strategic Overview
  • 14.3.6. MicroPort
    • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
    • 14.3.6.2. Product Portfolio
    • 14.3.6.3. Financial Overview
    • 14.3.6.4. SWOT Analysis
    • 14.3.6.5. Strategic Overview